熱門資訊> 正文
Needham表示，文献表明ARR增长可能超过10%
2025-12-18 03:30
- Docusign (DOCU) is capable of hitting — and surpassing — 10% growth in annual recurring revenue, investment firm Needham said, after a recent meeting with company management.
- “The change in billings guidance to [annual recurring revenue] guidance garnered the most interest among those attending the [earnings] call, given the audience questions we fielded during the call,” Needham analyst Scott Berg wrote in a note to clients. “Our key takeaways from the call were: a stable and consistent demand environment, IAM showing strong early adoption and usage trends within its 276k direct sales customers, ARR replacing billings to reduce early renewals & deal timing noise, and OpenAI concerns during the previous quarter are seemingly overblown as the company should actually benefit through integrations with [large language models].” Berg has a Hold rating on Docusign.
- Docusign shares were lower in late afternoon trading on Wednesday.
More on DocuSign
- Docusign, Inc. (DOCU) Presents at 53rd Annual Nasdaq Investor Conference Transcript
- Docusign: A Cheap SaaS Growth Play
- DocuSign: A Value Buy As Net Retention Improves
- Intel, Qualcomm, Adobe, others seen as 'AI losers,' Wedbush says
- Notable analyst calls this week: Novartis, Albemarle and Zscaler among top picks
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
